Search

11 Apr 2022: BOADICEA is a platform developed by researchers at the Department of Public Health and Primary Care that calculates the risk of breast cancer.

16 Mar 2022: New grafting techniqe supported by Cambridge Enterprise and Ceres Agri-Tech could combat Cavendish banana disease

9 May 2022: COBRAS Concrete Bridge Assessment Program is a yield-line analysis software for assessing the ultimate load capacity of concrete structures.

11 Apr 2022: HappyShield provides a barrier from splashes and sprays of infected bodily fluids and can be cleaned and reused indefinitely.

28 Apr 2022: Cambridge Enterprise leads £1 million investment in 52 North Health, a UK and US-based med-tech start-up.

9 May 2022: Hybridoma cell line producing YTH 24.5 antibodies raised against human CD45 which are rat monoclonal antibodies of the IgG2b isotype.

14 Jun 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 14 June 2022. Cambridge Enterprise co-leads £2.4m investment in spin-out developing ADC cancer therapeutics. Share:. Spirea Limited, a University of Cambridge spin-out company created

11 Apr 2022: We ran a knowledge exchange programme on research commercialisation for three southern African universities in 2019.

9 May 2022: Hybridoma cell line producing YTH 81.5 antibodies raised against human CD11a which are rat monoclonal antibodies of the IgG2a isotype.

4 Jul 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 6 June 2022. Joint Harvard-Cambridge spin-out closes $50m Series A to drive biomolecular condensate drug discovery. Share:. a joint spin-out from the University of Cambridge and Havard

9 May 2022: Hybridoma cell line producing YFC 120.5 antibodies raised against human CD16 which are rat monoclonal antibodies of the IgG2b isotype.

11 Apr 2022: investment. Less than five years later, we again released news about the company. ... This time, however, the news was the completion of a $9.5 million Series A funding round.

9 May 2022: Hybridoma cell line producing YTH 54.12 antibodies raised against human CD45 which are rat monoclonal antibodies of the IgG2b isotype.

23 Mar 2022: Tenyks, a University of Cambridge spin-out focused on helping machine learning engineers build better, safer artificial intelligence, has raised a $3.4 million seed round.

9 May 2022: Hybridoma cell line producing YFC118.12 antibodies raised against human CD18 which are rat monoclonal antibodies of the IgG2b isotype.

11 Apr 2022: Apollo Therapeutics was launched as a £100 million biopharmaceutical company in June 2021.

15 Nov 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 1 November 2022. Cambridge Enterprise licenses unique new device for cancer diagnosis. Share:. Transforming the process of prostate cancer diagnosis. This month will see the launch of a

9 May 2022: Hybridoma cell line producing YTH 913.12 antibodies raised against human CD28 which are rat monoclonal antibodies of the IgG2b isotype.

20 Sep 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 20 September 2022. Cambridge Enterprise, Cambridge Innovation Capital, and University launch Innovate Cambridge. Share:. Cambridge Enterprise, Cambridge Innovation Capital, and the

22 Mar 2022: When Cambridge Enterprise was looking to make a film about Consultancy Services, Dr Hugh Hunt, Cambridge University Reader in Engineering Dynamics and...